The nightly 'autopsy' isn't just about removing waste; it's a decision-making process about what gets cleared and what triggers deeper cellular action. Current models focus on parenchymal glymphatic flow and autophagy, but miss a key regulatory hub: the drainage interface. I hypothesize that sleep-dependent suppression of Type I interferon (IFN-I) signaling in the nasopharyngeal plexus is a master switch that determines whether neural debris is passively cleared or actively triggers pathological autophagy and inflammation.

The nasopharyngeal plexus isn't a passive sewer pipe; it's an immunologically active gateway. Aged mice show heightened IFN-I in its lymphatic endothelial cells, coinciding with impaired CSF drainage to deep cervical lymph nodes [source]. During healthy sleep, the large-amplitude CSF oscillations (~0.05 Hz) [source] may physically and chemically maintain this gateway in a low-IFN, permissive state for bulk clearance. Sleep loss flips this switch. Sympathetic hyperactivity and rising norepinephrine [source] don't just constrict interstitial space; they directly activate IFN-I pathways in these endothelial cells and resident immune cells at the plexus.

Here's the critical mechanistic leap: elevated IFN-I at this choke point doesn't just slow drainage. It acts as a signal back into the brain parenchyma. Aβ and tau fibrils, which are potent activators of cGAS-STING and other cytosolic DNA sensors, may be 'flagged' by local IFN-I at the plexus. This creates a feedback loop where undrained debris promotes IFN-I, which further impairs drainage and, crucially, orchestrates a specific, maladaptive autophagic response in neurons.

Instead of the targeted, housekeeping mitophagy seen in circadian-regulated sleep [source], IFN-I signaling during forced wakefulness may induce a stressed, bulk autophagy. This is less efficient for clearing specific aggregates and more likely to deplete healthy organelles, accelerating proteostatic collapse. This explains the paradox where sleep deprivation impairs autophagy in some brain regions while activating microglia [source]: the system is in a conflicted state—receiving 'clear debris' signals (IFN-I) but lacking the synchronized, low-inflammation environment (sleep) to execute it properly. Microglia activation then becomes a default, inflammatory response to the mounting backlog.

Testable Predictions:

1. Direct Measurement: In sleep-restricted rodents or humans, we should see a dramatic, sleep-stage-specific increase in IFN-α/β protein and mRNA within nasopharyngeal plexus lymphatic endothelial cells, preceding or coinciding with markers of impaired CSF tracer clearance.
2. Causal Intervention: Local, targeted knockdown of IFN-I receptor (IFNAR1) specifically in the nasopharyngeal plexus of sleep-deprived animals should partially rescue glymphatic function and reduce markers of maladaptive neuronal autophagy (e.g., p62 accumulation, mitophagy dysregulation) in the hippocampus and cortex.
3. Human Correlation: In patients with chronic insomnia or sleep apnea, CSF levels of IFN-α should correlate positively with biomarkers of impaired autophagy (e.g., altered LC3-II/I ratio in exosomes) and inversely with CSF Aβ42 clearance rates, independent of total amyloid load.

This model positions sleep not merely as a time for clearance, but as a necessary suppression of a specific neuroimmune alarm (IFN-I) at the brain's exit. Without this nightly suppression, the drainage checkpoint itself becomes a source of pathogenic signaling that corrupts the very autophagic processes meant to protect the brain, turning triage into a cascade of dysfunction.